- Home
- INMB vs RMCO Comparison
INMB vs RMCO Comparison
Compare INMB & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INMB | RMCO |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.1M | 45.7M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | INMB | RMCO |
|---|---|---|
| Price | $1.59 | $2.95 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $4.30 | N/A |
| AVG Volume (30 Days) | ★ 488.2K | 32.5K |
| Earning Date | 10-30-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 0.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $50,000.00 | ★ $3,798,352.00 |
| Revenue This Year | $264.29 | $531.90 |
| Revenue Next Year | $14,337.26 | $200.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 19.05 | ★ 445.90 |
| 52 Week Low | $1.38 | $0.91 |
| 52 Week High | $11.64 | $4.76 |
Technical Indicators
Market Signals| Indicator | INMB | RMCO |
|---|---|---|
| Relative Strength Index (RSI) | 38.47 | 63.95 |
| Support Level | $1.75 | $2.30 |
| Resistance Level | $1.90 | $2.92 |
| Average True Range (ATR) | 0.12 | 0.17 |
| MACD | -0.04 | 0.09 |
| Stochastic Oscillator | 0.00 | 100.00 |
Price Performance
Historical ComparisonAbout INMB INmune Bio Inc.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About RMCO Royalty Management Holding Corporation
Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.